Actinium Pharmaceuticals (ATNM) Asset Utilization Ratio (2021 - 2026)

Actinium Pharmaceuticals (ATNM) posted quarterly Asset Utilization Ratio of 0.0 for Q4 2025, down 17.19% quarter-over-quarter from 0.0 in Q3 2025.

Actinium Pharmaceuticals (ATNM) Asset Utilization Ratio (2021 - 2026) Analysis & Trends

Actinium Pharmaceuticals (ATNM) has reported Asset Utilization Ratio for 3 consecutive years, with 0.0 the latest figure, recorded in Q4 2025.

In Q4 2025, Asset Utilization Ratio changed N/A year-over-year to 0.0; the TTM figure through Dec 2025 stood at 0.0 (changed N/A YoY), while the FY2025 annual figure was 0.0, changed N/A from the prior year.
Asset Utilization Ratio eased to 0.0 in Q4 2025 per ATNM's latest filing, from 0.0 in the prior quarter.
Across five years, Asset Utilization Ratio topped out at 0.02 in Q1 2022 and bottomed at 0.0 in Q4 2025.
Historically, Asset Utilization Ratio has averaged 0.01 across 3 years, with a median of 0.01 in 2021.
On a YoY basis, Asset Utilization Ratio climbed as much as 114.64% in 2022 and fell as far as 35.74% in 2022.
Actinium Pharmaceuticals' Asset Utilization Ratio stood at 0.01 in 2021, then slumped by 35.74% to 0.01 in 2022, then plunged by 71.95% to 0.0 in 2025.
Business Quant data shows ATNM's Asset Utilization Ratio at 0.0 in Q4 2025, 0.0 in Q3 2025, and 0.01 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	138.64 Bn	130.78 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	85.89 Bn	77.90 Bn	3.93 Bn	0.38
3	Argenx Se	65.11 Bn	59.93 Bn	1.37 Bn	-
4	Moderna	55.83 Bn	50.69 Bn	52.00 Mn	0.20
5	BeOne Medicines	42.01 Bn	36.91 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.63 Bn	28.32 Bn	992.69 Mn	0.90
7	BioNTech SE	27.65 Bn	9.26 Bn	668.28 Mn	0.13
8	Insmed	27.46 Bn	26.30 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.30 Bn	26.47 Bn	-	0.13
10	Actinium Pharmaceuticals	34.85 Mn	34.85 Mn	-	0.82

Download Data